DATROWAY
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for DATROWAY, covering 2025-01-17 to 2026-02-09. Get the full timeline:
Most recent: EMA Authorised: Datroway (datopotamab deruxtecan) — Daiichi Sankyo Europe GmbH